Updates on dyslipidemia in patients with diabetes
- PMID: 37347218
- PMCID: PMC10445203
- DOI: 10.1111/jdi.14042
Updates on dyslipidemia in patients with diabetes
Conflict of interest statement
KY has participated on advisory panels for AstraZeneca, Kowa Company and Novo Nordisk Pharma; and has received research grants from Abbott Diabetes care, Astellas Pharma, Bayer Yakuhin, Daiichi Sankyo Company, Eli Lily Japan, Kowa Company, Merck Sharp and Dohme, Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, Novo Nordisk Pharma, Ono Pharmaceutical, Pfizer, Shionogi, Sumitomo Dainippon Pharma, Taisho Toyama Pharmaceutical Company, and Takeda Pharmaceutical Company. The other authors declare no conflict of interest.
Approval of the research protocol: N/A.
Informed consent: N/A.
Registry and the registration no. of the study/trial: N/A.
Animal studies: N/A.
References
-
- Cholesterol Treatment Trialists C, Kearney PM, Blackwell L, et al. Efficacy of cholesterol‐lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta‐analysis. Lancet 2008; 371: 117–125. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical